Alliqua BioMedical Inc (ALQA)

1.01
NASDAQ : Health Care
Prev Close 1.06
Day Low/High 1.00 / 1.04
52 Wk Low/High 0.70 / 4.74
Avg Volume 105.40K
Exchange NASDAQ
Shares Outstanding 29.67M
Market Cap 31.45M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

6 Stocks Under $10 Making Big Moves Higher

6 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering breakout trades.

6 Stocks Under $10 Making Big Moves Higher

6 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Alliqua BioMedical, Inc. Reports First Quarter Financial Results

Alliqua BioMedical, Inc. Reports First Quarter Financial Results

Revenue Growth of 120% year-over-year; Reaffirms Fiscal Year 2016 Guidance

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering breakout trades.

Alliqua BioMedical Presents At The Spring 2016 SAWC Meeting

Alliqua BioMedical Presents At The Spring 2016 SAWC Meeting

Event to Feature New Data from the Company's MIST Therapy® Systems

Alliqua BioMedical, Inc. Announces Participation In The Blue Cross Blue Shield Association's Evidence Street Pilot Program

Alliqua BioMedical, Inc. Announces Participation In The Blue Cross Blue Shield Association's Evidence Street Pilot Program

Biovance® Included in Guideline for Engineered Skin and Soft Tissue Substitutes

Alliqua BioMedical, Inc. Reports Fourth Quarter And Fiscal Year 2015 Financial Results

Alliqua BioMedical, Inc. Reports Fourth Quarter And Fiscal Year 2015 Financial Results

Revenue Growth of 214% in FY 2015; Provides Fiscal 2016 Revenue Outlook

Alliqua Biomedical Announces Partnership With Human Longevity Inc., Under Existing Licensing Agreement

Alliqua Biomedical Announces Partnership With Human Longevity Inc., Under Existing Licensing Agreement

Future Collaboration Focused on Developing Differentiated and Novel HCTP Technologies

Insider Trading Alert - JMP, LDL And ALQA Traded By Insiders

Insider Trading Alert - JMP, LDL And ALQA Traded By Insiders

Stocks with insider trader activity include JMP, LDL and ALQA

Alliqua BioMedical, Inc. Reports Third Quarter Financial Results

Alliqua BioMedical, Inc. Reports Third Quarter Financial Results

Revenue Growth of 236% year-over-year in Q3; Gross Margin Increases to 67%

Alliqua BioMedical, Inc. Reports Second Quarter Financial Results

Alliqua BioMedical, Inc. Reports Second Quarter Financial Results

Revenue Growth of 202% Year-Over-Year in Q2; Gross Margin Increases to 56%